{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:11:27Z","timestamp":1784308287676,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["105758\/Z\/14\/Z"],"award-info":[{"award-number":["105758\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0012"],"award-info":[{"award-number":["ANR-18-RHUS-0012"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["NCT01248195"],"award-info":[{"award-number":["NCT01248195"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopsych.2020.11.014","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:11:17Z","timestamp":1606169477000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-0810","authenticated-orcid":false,"given":"Thomas A.","family":"Pollak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-8695","authenticated-orcid":false,"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Iyegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-0135","authenticated-orcid":false,"given":"James","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Jezequel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-4100","authenticated-orcid":false,"given":"Stephane","family":"Jamain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Groc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Egerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2020.11.014_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.schres.2014.05.001","article-title":"Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder","volume":"157","author":"Pearlman","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2020.11.014_bib2","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: A systematic review and meta-analysis","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2020.11.014_bib3","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41467-017-01700-3","article-title":"Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients","volume":"8","author":"J\u00e9z\u00e9quel","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2020.11.014_bib4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopsych.2017.06.015","article-title":"Cell- and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project","volume":"82","author":"J\u00e9z\u00e9quel","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2020.11.014_bib6","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000280","article-title":"Neuroleptic intolerance in patients with anti-NMDAR encephalitis","volume":"3","author":"Lejuste","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.biopsych.2020.11.014_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/15563650.2013.829235","article-title":"Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: An etiology worth considering in the differential diagnosis of delirium","volume":"51","author":"Punja","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2020.11.014_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A\u00a0clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2020.11.014_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.schres.2014.11.001","article-title":"Immunotherapy for patients with acute psychosis and serum N-methyl D-aspartate receptor (NMDAR) antibodies: A description of a treated case series","volume":"160","author":"Zandi","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2020.11.014_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1192\/bjo.2018.8","article-title":"The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis","volume":"4","author":"Scott","year":"2018","journal-title":"BJPsych Open"},{"key":"10.1016\/j.biopsych.2020.11.014_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2014.10.007","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","volume":"176","author":"Kayser","year":"2016","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2020.11.014_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fimmu.2017.00181","article-title":"Autoantibodies against the N-methyl-d-aspartate receptor subunit NR1: Untangling apparent inconsistencies for clinical practice","volume":"8","author":"Ehrenreich","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.biopsych.2020.11.014_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(18)30252-9","article-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): A three-phase switching study","volume":"5","author":"Kahn","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2020.11.014_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A\u00a0depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2020.11.014_bib16","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2020.11.014_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.biopsych.2020.11.014_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: Proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/eip.12562","article-title":"Individual factors influencing the duration of untreated psychosis","volume":"13","author":"Souaiby","year":"2019","journal-title":"Early Interv Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.schres.2013.05.011","article-title":"Demographic, socio-environmental, and substance-related predictors of duration of untreated psychosis (DUP)","volume":"148","author":"Broussard","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2020.11.014_bib21","article-title":"Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis [published online ahead of print Oct 19]","author":"Pollak","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jamapsychiatry.2015.2324","article-title":"Heterogeneity of psychosis risk within individuals at clinical high risk: A meta-analytical stratification","volume":"73","author":"Fusar-Poli","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib23","first-page":"2378","article-title":"Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis","volume":"264","author":"Zhang","year":"2017","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.biopsych.2020.11.014_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jamapsychiatry.2015.2313","article-title":"Prognosis of brief psychotic episodes: A meta-analysis","volume":"73","author":"Fusar-Poli","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.semarthrit.2016.07.004","article-title":"Self-limiting arthritis among patients fulfilling the 2010 ACR\/EULAR classification criteria for rheumatoid arthritis in a very early arthritis cohort","volume":"46","author":"Norli","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.biopsych.2020.11.014_bib26","article-title":"Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: A translational study from chronic life stress to brain injury [published online ahead of print Feb 24]","author":"Pan","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.11.014_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.25460","article-title":"N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit","volume":"85","author":"Wenke","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2020.11.014_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: An international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.biopsych.2021.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320320758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320320758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:02:56Z","timestamp":1777377776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322320320758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0006322320320758"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.11.014","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}